BioCentury
ARTICLE | Clinical News

Alutard SQ: Phase III data; Marketed outside the U.S. to treat pollen, dust mite, animal hair, insect sting and grass allergies

March 17, 2003 8:00 AM UTC

In a double-blind, placebo-controlled U.K. Phase III trial in 410 patients, those given Alutard had reduced allergy symptoms and rated their average symptom score >30% lower than that of placebo patie...